Literature DB >> 3171005

Evaluation of a radioimmunoassay for histamine measurement in biologic fluids.

P McBride1, D Bradley, M Kaliner.   

Abstract

A new radioimmunoassay for the measurement of histamine in biologic fluids was evaluated. Assay selectivity and specificity were achieved by "succinyl-glycinamide derivatization" of histamine in samples to mimic the immunogen used to generate the monoclonal antibody. The assay exhibits a linear response from 0.1 to 5.0 ng/ml of histamine and the monoclonal antibody used has partial recognition of only N-methylhistamine (other than histamine). With minimal modifications, the assay can accurately measure histamine in plasma, urine, and buffer. Normal ranges for human subjects were established: plasma levels are 0.193 +/- 0.08 ng/ml (n = 40) and urine levels are 20.9 +/- 11.2 micrograms histamine/gm creatinine (n = 10).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171005     DOI: 10.1016/0091-6749(88)90977-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Plasma histamine levels during induction of anesthesia with propofol in dogs.

Authors:  H Mitsuhata; R Shimizu
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

2.  Post-burn temporal dynamics of blood plasma histamine during the initial 6 days from injury.

Authors:  Miles C Smalley; Joe Olivi; Krisi A Causa; Manoj Pathak; Cindy L Austin; Simon J Thompson
Journal:  Int J Burns Trauma       Date:  2020-06-15

Review 3.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

4.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

5.  The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.

Authors:  D G Sciberras; S Jordan; D Gill; N S Baber; I James
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

6.  Plasma histamine in patients with chronic renal failure and nephrotic syndrome.

Authors:  D S Gill; V A Fonseca; M A Barradas; R Balliod; J F Moorhead; P Dandona
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

7.  Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide (CGRP).

Authors:  S P Rangi; S Sample; M H Serwonska; G A Lenahan; E J Goetzl
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

8.  Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.

Authors:  D P Healy; J V Sahai; S H Fuller; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

9.  Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.

Authors:  M J Rybak; E M Bailey; L H Warbasse
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

10.  Changes in the plasma histamine concentration after the administration of vecuronium bromide.

Authors:  H Mitsuhata; S Matsumoto; K Enzan; M Yabe; H Terada
Journal:  J Anesth       Date:  1991-01       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.